Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Trading Up ∞
The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The company has a market cap of C$21.54 million and a P/E ratio of -12.66. The business has a 50-day moving average price of C$2.00 and a two-hundred day moving average price of C$2.00.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Read More
- Five stocks we like better than Liberty Biopharma
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Investing In Automotive Stocks
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
